Research into cholesterol and heart disease

Heart Disease Australia's number 1 killer




:
30% of AUSTRALIANS DIE FROM HEART ATTACK

Coronary artery disease is the clogging or blockage of the coronary arteries caused by atherosclerosis.

High cholesterol diets, lack of exercise or your genetics can cause cholesterol to build up in the arteries. 52 Australians die each day from heart attack.




Breakthrough Discovery



blog-post
GERMAN SCIENTISTS DISCOVER TREATMENT TO REMOVE PLAQUE

In 2016 a team of scientists from Germany's Bonn University discovered a new compound that reduced plaque in mice by over 40% in as little as 4 weeks.

The new cyclodextrin compound (CAVADEX®) was also tested on human plaque and they discovered it affected the plaque in a similar way.


Breakthrough discovery !!
Link to the published article




CAVADEX® entraps and removes harmful cholesterol from plaque
blog-post


Follow the Science




blog-post

CAVADEX® developed by Cholrem Pty Ltd



CAVADEX® entraps and removes harmful cholesterol from plaque


CAVADEX® (Hydroxypropyl beta cyclodextrin) is comprised of seven sugar molecules bound together in a ring (cyclic oligosaccharide).

The ring-shaped, three-dimensional structure has a hydrophobic cavity in its center, which is capable of trapping cholesterol and lipids. It has been used extensively as an excipient in the food, deodorant, and drug industry for the past century, and it is generally recognized as safe (GRAS).

As an active ingredient, CAVADEX® entraps and removes intracellular cholesterol and lipids that can cause injury to the kidneys and other organs, including the brain and liver.

blog-post

CAVADEX® captures the cholesterol

:

CAVADEX® captures the cholesterol





blog-post

Angiogram: First patient has plaque reduction in just 4 weeks

CHOLREM Pty Ltd LEADS THE WORLD IN RESEARCH

CAVADEX® was administered to our first patient in our Melbourne clinic in April 2019 and within 4 weeks the plaque was significantly reduced!

CAVADEX® circulates around the cardiovascular system removing built up cholesterol and plaque resulting in significant plaque reduction in as little as 4 weeks.

CAVADEX® is absorbed via intravenous application, as an enema and now as a low absorption tablet.

Regular low doses of CAVADEX® can have a significant effect on plaque build up


Click here to
learn more about CAVADEX®


Must Read Scientific Articles

Contact us

: